Table 2.

Baseline characteristics of donors

Donor Characteristics (total N=782)Alemtuzumab (N=87)Basiliximab (N=522)ATG (N=173)P Value
Sex, n (%)0.26
 Male41 (47)294 (56)92 (53)
 Female46 (53)228 (44)81 (47)
Race, n (%)0.86
 White80 (92)475 (91)154 (89)
 Black2 (2)19 (4)5 (3)
 Other5 (6)28 (5)14 (8)
Donor type, n (%)0.0006
 Live47 (54)177 (34)57 (33)
 DBD26 (30)250 (48)71 (41)
 DCD14 (16)95 (18)45 (26)
Age at donation (yr), mean (range)43.3 (6.0–69.0)44.4 (1.0–76.0)42.7 (4.0–74.0)0.34
BMI (kg/m2), mean (range)27.8 (15.1–59.9)28.0 (12.2–60.6)28.7 (12.7–63.3)0.46
KDPI, %±SD41±2851±2649±280.10
CIT (h), mean (range)12.9 (1.0–27.2)14.9 (0.5–34.7)15.6 (1.0–40.9)0.06
Deceased donor only CIT (h), mean (range)15.6 (6.7–27.2)15.6 (4.5–34.7)16.7 (2.5–40.9)0.25
  • ATG, anti-thymocyte globulin; DBD, donation by brainstem death; DCD, donation by cardiac death; BMI, body mass index; KDPI, Kidney Donor Profile Index; CIT, cold ischemia time.